As of Apr 20
| +0.19 / +0.32%|
The 21 analysts offering 12-month price forecasts for Merck & Co Inc have a median target of 65.00, with a high estimate of 90.00 and a low estimate of 56.00. The median estimate represents a +10.49% increase from the last price of 58.83.
The current consensus among 24 polled investment analysts is to Buy stock in Merck & Co Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.